The nutritional status has been a useful predictor of survival in various cancers. However, the utility of a new nutritional screening tool specifically for oncology patients (NUTRISCORE) to detect nutritional risk for malnutrition in patients with advanced non-small cell lung cancer has not been examined. The aim of this study was to assess nutritional risk for malnutrition status estimated by NUTRISCORE as prognostic factor in Mexican patients with advanced non-small cell lung cancer. We evaluated 126 patients with advanced lung cancer (IIIB and IV). Demographic and clinical data were collected. Nutritional risk status was estimated by NUTRISCORE at diagnosis in routine screening evaluation before systemic treatment and divided into risk and no risk groups. Kaplan-Meier survival analysis and the log-rank test were used to calculate OS. Univariate and multivariate analysis to identify variables associated with OS was assessed using Cox regression model. A total of 126 elderly advanced lung cancer patients were included between 2013 and 2018. Among the included patients, the median age was 63.39 (range: 29-86 years), and 62 (49.2 %) patients were females and 64 (50.8 %) were males. Seventy one (56.3%) and 56(43.7%) patients were assigned to nutritional risk group and no risk group, respectively. Median overall survival (OS) was worse in the nutritional risk (risk vs no risk, 12.6 vs 46.6 months; p 0.000). In multivariate analysis, nutritional risk involuntary weight loss (p=0.020), and decreased appetite (p=0.001) were independent prognostic factors for OS. The assessment of NUTRISCORE risk could assist the identification of patients with advanced lung cancer with poor prognosis and a factor to attend in and probe in clinical trials.
Read full abstract